Results 221 to 230 of about 151,098 (403)
ABSTRACT Pirtobrutinib is a reversible Bruton tyrosine kinase (BTK) inhibitor. In vitro, pirtobrutinib is metabolized by cytochrome P450 (CYP) 3A4 and uridine 5′‐diphosphoglucuronosyl transferases (UGTs) and causes reversible and time‐dependent inhibition and induction of CYP3A4.
Dan‐Dan Tian +3 more
wiley +1 more source
Retrospective analysis of the analgosedative efficacy and safety of midazolam combined with fentanyl in mechanically ventilated neonates. [PDF]
Lin F, Lin S, Cai W, Ren Y.
europepmc +1 more source
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
E. Ng, A. Taddio, A. Ohlsson
semanticscholar +1 more source
ABSTRACT The agricultural sector is pivotal to the economies of most developing countries. In Zambia, the agricultural sector is dominated by smallholder maize farmers who play a key role in ensuring food security, employment, and rural development. Despite receiving a significant share of the agricultural budget, smallholder maize farmers continue to ...
Maureen Lupunga Malesu +2 more
wiley +1 more source
Dexmedetomidine Versus Midazolam for Propofol Sparing in Procedural Sedation of Children With Leukemia: A Consecutive Case Series. [PDF]
Squillaci D +8 more
europepmc +1 more source
Violence, Volition, and Volatility: The Embodied Subjectivity of Women in Cults
This paper explores the embodied experience of 25 women who are former cult members. By delving into the stories of three protagonists, we examine how these women engaged with and possibly redefined the cult's socially constructed notion of womanhood.
Shirly Bar‐Lev, Michal Morag
wiley +1 more source
Esketamine versus sufentanil as analgesics for sedation during painless gastrointestinal endoscopy: a double-blinded randomized controlled trial. [PDF]
Li TT +5 more
europepmc +1 more source
Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit [PDF]
Shaiana Vilella Hartwig +2 more
openalex +1 more source

